How to get AOD-9604 peptide: the honest, legal route

Last updated 2026-07-24

What is AOD-9604 and why do people want it?

AOD-9604 is a fragment of human growth hormone, specifically the region of the HGH molecule (amino acids 176-191) that researchers once believed drove fat metabolism without touching blood sugar or tissue growth. The idea was clever: keep the fat-burning piece, drop the parts of HGH that cause the side effects everyone worries about (joint swelling, insulin resistance, tissue overgrowth). That rationale is why it got attention as an obesity drug candidate in the 2000s. A 2006 review of obesity drugs in clinical development covered AOD-9604 alongside other candidates being tested for fat-loss potential at that time ^[1]. It's also why bodybuilding and biohacking forums still talk about it as a "safer" alternative to full HGH. Here's the problem: wanting it and there being a legitimate product to get are two different things. There is no FDA-approved AOD-9604 drug. Nothing with that name appears in the FDA's Drugs@FDA database of approved products ^[2]. Anyone offering you a prescription bottle of "AOD-9604" from a retail pharmacy is not selling you an approved medication, because that medication doesn't exist.

Is AOD-9604 FDA-approved or legal to buy?

No. AOD-9604 has never received FDA approval for any use, and it does not appear on the FDA's list of bulk drug substances approved for compounding under section 503A of the Food, Drug and Cosmetic Act ^[3], nor on the 503B outsourcing facility bulks list ^[4]. Both lists are maintained under specific federal regulations (21 CFR 216.23 for 503A, 21 CFR 216.24 for 503B) ^[5][6], and a substance has to be nominated and reviewed before it can legally go into a compounded human drug product. That matters practically. Compounding pharmacies operate under 21 U.S.C. 353a, which lets a licensed pharmacist compound a drug for an identified patient based on a valid prescription, using components that meet applicable standards ^[7]. If the active ingredient isn't on the approved bulks list, a compounder using it for a drug product is operating outside that framework, whatever the marketing on the vial says. What you'll actually find selling AOD-9604 online falls into two buckets. First, research chemical suppliers who sell it labeled "not for human consumption, research use only," which is the standard label under FDA's intended-use framework (21 CFR 201.128) for a substance not cleared for human dosing ^[8]. Second, some telehealth or wellness clinics that source it through a compounding pharmacy and administer it under a provider's supervision, treating it as an off-label or research-use offering rather than an approved drug. Neither path involves an FDA-approved AOD-9604 medication, because none exists.

Does AOD-9604 actually work for fat loss? What do the trials show?

This is the part that should shape your whole decision, so read it before you read anything else on this topic. AOD-9604 went through human obesity trials in the mid-2000s. A 2004 report in Current Opinion in Investigational Drugs on AOD-9604's metabolic effects is one of the core pieces of that record ^[9]. The honest summary, and the one this site holds to, is that the weight-loss signal in human trials did not separate convincingly from placebo. That's not a minor caveat. It's the central fact about this compound's human evidence base. Compare that to what's needed for an obesity drug to get approved today: FDA-approved products like semaglutide and tirzepatide have Phase 3 trial data showing weight loss clearly beating placebo by double-digit percentages, published in peer-reviewed journals with dose-response curves and years of follow-up. AOD-9604 never produced that kind of data. It appeared in broader obesity-drug-pipeline reviews as a candidate under development ^[1], but the trials that would have needed to show a clean separation from placebo before regulatory review, didn't. If you're comparing options for fat loss and require evidence of real people losing more weight than a placebo group, look at drugs with FDA approval and published Phase 3 outcomes, not AOD-9604. For the deeper trial-by-trial breakdown, see our AOD-9604 peptide evidence review.

What's the difference between research-grade AOD-9604 and pharmaceutical grade?

"Research grade" means a supplier sells the peptide as a chemical for laboratory use, not for injection into a person, and typically doesn't guarantee sterility, purity verification per batch, or dosing accuracy suitable for human administration. "Pharmaceutical grade" implies manufacturing under controlled, verifiable standards meant for human use, which for AOD-9604 doesn't formally exist because no approved drug product exists to set that standard. When a compounding pharmacy prepares AOD-9604 for a clinic, it's working from bulk peptide, not a pharmaceutical-grade finished product regulated the way an approved drug is. The quality of that bulk material, and the pharmacy's own quality controls, are what actually determine what ends up in the vial. This is why sourcing matters as much as, arguably more than, the peptide name itself. A 2016 mass spectrometry method paper on screening small peptides in urine notes the analytical difficulty of detecting and confirming peptides under 2 kDa cleanly, which is relevant context for how hard it is to verify what's actually in a vial without lab-grade testing ^[10]. Buying based on a supplier's word alone, without any certificate of analysis, means you genuinely don't know what you're injecting.

How do you find a legitimate provider or pharmacy for AOD-9604?

If you're going to pursue this despite the weak trial record, the safer path (relatively speaking) runs through a licensed provider working with a compounding pharmacy, not a bare research-chemical website with no medical oversight. What separates a defensible source from a risky one:

AOD-9604 Co reviews provider options and, where a route is credentialed, will name the fulfilling pharmacy partner directly rather than pointing you at an anonymous storefront. That doesn't change the trial data. It just means if you're going to do this, do it with a paper trail and a person accountable for what's in the vial, not a warehouse in another country. If you haven't already, read the dosing and reconstitution basics before going further: AOD-9604 dosage and AOD-9604 how to reconstitute cover the mechanics people ask about most.

Will AOD-9604 show up on a drug test or violate anti-doping rules?

AOD-9604 doesn't trigger the WADA hGH isoform immunoassay, the standard test used to detect exogenous growth hormone in athletes. A 2013 study in Drug Testing and Analysis specifically tested this and reported that AOD-9604 does not influence that immunoassay ^[11]. That's a narrow, specific finding: it means this particular test won't flag AOD-9604 the way it flags full-length HGH. That doesn't mean AOD-9604 is untestable or permitted. Anti-doping labs have developed other detection approaches for small peptides. A 2014 review in the Journal of Pharmaceutical and Biomedical Analysis covers analytical methods for detecting emerging therapeutics and non-approved drugs, including peptides like this one, in doping controls ^[3]. A separate 2014 review in Expert Review of Proteomics on detecting peptidic drugs and analogs in sports doping discusses the broader challenge of catching peptide fragments and designer analogs ^[8]. And the 2016 direct-urine-injection mass spec method was built specifically to expand screening for peptides under 2 kDa, AOD-9604's molecular size range, precisely because standard immunoassays miss them ^[10]. If you're a tested athlete, the practical answer is: assume detection methods are catching up, and check your sport's prohibited list rather than relying on "it doesn't trigger the standard test" as a green light.

What are the known safety and side effect concerns?

Human safety data on AOD-9604 specifically, outside the original obesity trials, is thin. Two 2026 reviews give a sense of where the broader peptide-therapy field stands: one in the Journal of the American Academy of Orthopaedic Surgeons Global Research & Reviews covers therapeutic peptides in orthopaedics generally, including applications and challenges across the peptide class ^[12]. Another in Sports Medicine reviews safety and efficacy across approved and unapproved peptide therapies used for musculoskeletal injuries and athletic performance ^[13], underscoring that this is a fast-moving, unevenly regulated space where AOD-9604 sits among many similar compounds with limited human safety data outside sponsor-run trials. Because there's no FDA-approved product, there's no FDA-mandated adverse event reporting system tracking real-world AOD-9604 use the way there is for approved drugs. Whatever safety picture exists comes from the original trial-era literature ^[9][1] and general peptide-class reviews, not a large postmarket safety database. For a full rundown of what's reported anecdotally versus what's actually been studied, see AOD-9604 peptide side effects.

How much does AOD-9604 cost, and is it worth the money?

Pricing varies widely because there's no standardized product. Research-chemical vials commonly run somewhere in the range of $30 to $100 for a small quantity, though price says nothing about purity or accuracy of contents. Compounded versions through a clinic typically cost more once you add provider visits, prescribing fees, and pharmacy markup, often landing in the range other compounded peptide programs charge per month. Given the trial record, the value question is blunt: you're paying for a compound whose human obesity trials didn't show weight loss clearly beating placebo ^[9][1]. If your goal is fat loss with a real evidence base, GLP-1 receptor agonists with FDA approval and published Phase 3 data are a better use of that budget for most people. If your interest in AOD-9604 is more about the fragment's growth-hormone-adjacent mechanism than proven weight loss, go in knowing that's an unproven bet, not a documented outcome. Check current listings and provider options at AOD-9604 peptide for sale before deciding anything.

What should you ask a supplier or provider before buying?

Ask these five things before you hand over money, whether it's a research-chemical site or a telehealth clinic: What pharmacy or lab actually compounds or manufactures this, by name? A legitimate provider will tell you. A vague answer is a red flag. Can you show a certificate of analysis for this specific batch? Purity and identity testing should be available, more than claimed. Is this being sold for human use or research use, and does the label match what you're being told verbally? If a seller tells you to inject it but the label says "research use only," that mismatch is the seller's legal cover, not your protection. What does the actual trial evidence say about weight loss versus placebo? If the answer glosses over the placebo problem ^[9][1], that's a marketing pitch, not an honest answer. Who is medically accountable if something goes wrong? A named prescriber and pharmacy give you someone to call. An anonymous storefront doesn't.

How does AOD-9604 compare to other fat-loss peptides and drugs?

The honest takeaway: if separation from placebo in a real trial is your bar, AOD-9604 doesn't clear it the way approved GLP-1 drugs do. It's not that AOD-9604 has zero research behind it, the fragment rationale and mechanism work are real and published ^[9][1]. It's that the specific outcome most people want it for, meaningful fat loss beyond placebo, isn't backed by a strong human result. Weigh that before you weigh cost or convenience.

Frequently asked questions

Can you buy AOD-9604 legally in the US?

You can legally buy it labeled as a research chemical, not for human use, since no FDA-approved AOD-9604 drug exists and it isn't on the FDA's 503A or 503B compounding bulks lists ^[6][7]. Some clinics offer compounded versions under provider supervision, but that sits outside the standard approved-drug framework.

Do you need a prescription for AOD-9604?

There's no FDA-approved product to prescribe in the traditional sense. Some telehealth clinics write orders for compounded AOD-9604 through a pharmacy operating under 21 U.S.C. 353a ^[4], but this differs from getting a prescription for an approved medication at a retail pharmacy.

Is AOD-9604 the same as HGH?

No. AOD-9604 is a synthetic fragment representing amino acids 176-191 of the human growth hormone molecule, designed to isolate the fat-metabolism region while leaving out the parts linked to growth and blood sugar effects. It is not full-length HGH and doesn't act the same way in the body.

Does AOD-9604 actually cause fat loss in humans?

Human obesity trials on AOD-9604 did not show weight loss that separated convincingly from placebo ^[1][5]. That's the central finding from the trial-era literature, and it's the reason this compound never reached FDA approval for weight management despite the plausible mechanism behind it.

Will AOD-9604 show up on a doping test?

A 2013 study found AOD-9604 does not influence the WADA hGH isoform immunoassay, the standard growth hormone detection test ^[9]. However, other detection methods for small peptides have since been developed ^[6][8][10], so assume anti-doping labs are working to close that gap.

What's the difference between research-grade and pharmaceutical-grade AOD-9604?

Research-grade peptide is sold for lab use with no guarantee of sterility or verified purity for human injection. Pharmaceutical-grade implies manufacturing to human-use standards, which formally doesn't exist for AOD-9604 since there's no approved drug product setting that benchmark.

How much does AOD-9604 cost?

Research-chemical vials commonly run roughly $30 to $100 depending on quantity and supplier, with wide variation and no standardized pricing since there's no approved product. Compounded clinic versions typically cost more once provider fees and pharmacy markup are added.

Is AOD-9604 safe?

Detailed human safety data specific to AOD-9604 outside early trials is limited. Broader peptide-class reviews from 2026 cover safety concerns across approved and unapproved peptide therapies generally ^[12][13], but there's no large postmarket safety database for AOD-9604 itself since no approved product exists to generate one.

What's a better alternative to AOD-9604 for fat loss?

FDA-approved GLP-1 receptor agonists like semaglutide and tirzepatide have published Phase 3 trial data showing weight loss clearly beating placebo, unlike AOD-9604's trial record ^[1][5]. If proven human evidence is your priority, those have a stronger evidence base.

How do I know if an AOD-9604 supplier is legitimate?

Ask for the name of the compounding pharmacy or lab, a certificate of analysis for the specific batch, and clarity on whether it's sold for research or human use. A named, checkable pharmacy partner and provider oversight are stronger signals than an anonymous storefront with no accountability.

Does AOD-9604 have any FDA approval status?

No. AOD-9604 doesn't appear in the FDA's Drugs@FDA database of approved products ^[11], and it isn't on the FDA's approved bulk drug substances lists for 503A or 503B compounding ^[6][7]. It has never received FDA approval for any indication.

Why did AOD-9604 fail to get approved as an obesity drug?

The core reason is the trial data: weight loss in human obesity trials did not separate convincingly from placebo ^[1][5]. Regulatory approval for an obesity drug requires trials clearly showing a benefit over placebo, and that bar wasn't met.

Can AOD-9604 be detected in a urine test?

Peptides under 2 kDa like AOD-9604 are difficult to detect with standard immunoassays, which is why newer methods, including a 2016 direct urine injection mass spectrometry approach, were developed specifically to expand screening for this size class ^[10].

Sources

1. Current Opinion in Investigational Drugs, 2004 (PMID 15134286): Reports on AOD-9604's metabolic effects from the trial-era research on this compound as an obesity candidate.
2. 21 CFR 216.23, the final 503A Bulks List: Establishes the federal regulation governing which bulk drug substances are approved for 503A compounding.
3. 21 CFR 216.24, the 503B Bulks List: Establishes the federal regulation governing which bulk drug substances are approved for 503B outsourcing facility compounding.
4. 21 U.S.C. 353a, pharmacy compounding: Sets the legal framework under which licensed pharmacists may compound drugs for identified patients with a valid prescription.
5. Obesity Drugs in Clinical Development, Current Opinion in Investigational Drugs, 2006 (PMID 16625817): Covers AOD-9604 among obesity drug candidates in clinical development during this period.
6. Analytical Approaches for Detection of Emerging Therapeutics, Journal of Pharmaceutical and Biomedical Analysis, 2014 (PMID 24906629): Reviews analytical methods for detecting emerging therapeutics and non-approved drugs including peptides in doping controls.
7. FDA, Bulk Drug Substances Nominated for Use in Compounding (current list): Lists substances nominated and under review for compounding use, showing AOD-9604's status relative to approved bulks lists.
8. 21 CFR 201.128, meaning of intended uses: Defines the intended-use framework that governs labeling substances as research use only versus for human consumption.
9. AOD-9604 Does Not Influence the WADA hGH Isoform Immunoassay, Drug Testing and Analysis, 2013 (PMID 24124033): Reports that AOD-9604 does not trigger a positive result on the standard WADA growth hormone isoform immunoassay.
10. Simplifying and Expanding Screening for Peptides <2 kDa, Journal of Separation Science, 2016 (PMID 26578461): Describes a mass spectrometry method developed to expand detection of small peptides under 2 kDa that standard immunoassays miss.
11. Drugs@FDA, FDA-Approved Drug Products Database: Confirms AOD-9604 does not appear as an FDA-approved drug product in the official database.
12. Therapeutic Peptides in Orthopaedics, JAAOS Global Research & Reviews, 2026 (PMID 41490200): Reviews applications and challenges of therapeutic peptides broadly, providing context on the regulatory and safety landscape of the peptide class.
13. Safety and Efficacy of Approved and Unapproved Peptide Therapies, Sports Medicine, 2026 (PMID 41966639): Reviews safety and efficacy data across approved and unapproved peptide therapies used for musculoskeletal injuries and athletic performance.